Blog

$Arielle Elkrief: Happy to share our paper – FMT as an effective treatment for refractory irColitis$

Photo of Arielle Elkrief taken from X/Twitter

Feb 1, 2024, 14:54

Arielle Elkrief: Happy to share our paper – FMT as an effective treatment for refractory irColitis

Arielle Elkrief, Assistant Professor and Principal Scientist at University of Montreal, shared a post by Cancer Immunology Research on X/Twitter:

“Happy to share our paper – Fecal microbiota transplantation (FMT) as an effective treatment for refractory Immune-Related Colitis (irColitis). We also characterized the faecal microbiome at symptom onset of irColitis and found enrichment of Proteobacteria such as E.Coli. Thanks to Jonathan Peled, David Faleck and of course the amazing Nick Waters.”

Quoting Cancer Immunology Research’s post:

“Online First: Fecal microbiota transplantation for immune-related colitis, by Arielle Elkrief, Jonathan U. Peled et al.”

$Arielle Elkrief: Happy to share our paper - FMT as an effective treatment for refractory irColitis 1$

Link to article.

Source: Arielle Elkrief/X and

Arielle Elkrief cancer Cancer Immunology Research David Faleck Fecal microbiota transplantation (FMT) Immune-Related Colitis (irColitis) Jonathan Peled Nick Waters OncoDaily Oncology University of Montreal

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology